Goodwill and Purchased Intangible Assets

12 Months Ended

Jun. 30, 2013

Goodwill and Purchased Intangible Assets

Goodwill and Purchased Intangible Assets

6. Goodwill and Purchased Intangible Assets

Goodwill

Goodwill as of June 30, 2013 and 2012 and changes in the carrying amount of goodwill for the respective periods are as follows (in thousands):

	Year Ended June 30, 2013		Year Ended June 30, 2012

Balance at the beginning of the period	$	59,215	$	54,474
Addition related to acquisition		77		—
Currency translation and other adjustments		76		—
Adjustments related to prior year acquisition(1)		—		4,741

Balance at the end of the period	$	59,368	$	59,215

(1): Primarily represents liabilities related to the TomoTherapy acquisition.

Purchased Intangible Assets

The Company's intangible assets associated with completed acquisitions are as follows:

(in thousands):

		June 30, 2013							June 30, 2012

	Useful Lives	Gross Carrying Amount		Accumulated Amortization			Net Amount		Gross Carrying Amount		Accumulated Amortization			Net Amount
	(in years)
Developed technology	5 - 6	$	46,747	$	(15,276	)	$	31,471	$	43,455	$	(9,161	)	$	34,294
Backlog	1.25		10,500		(10,500	)		—		10,500		(8,867	)		1,633
Distributor license	1.5 - 2.5		2,043		(1,618	)		425		1,860		(768	)		1,092
In-process research and development (CPAC)	Indefinite		—		—			—		12,800		—			12,800

		$	59,290	$	(27,394	)	$	31,896	$	68,615	$	(18,796	)	$	49,819

During the year ended June 30, 2013, the Company recorded an impairment charge of approximately $12.2 million related to IPR&D technology due to a decrease in projected future usage of the technology. The Company did not have an impairment of goodwill during the years ended June 30, 2013, 2012 and 2011.

Amortization expense, excluding impairment charges related to purchased intangible assets was $10.4 million, $16.2 million and $1.2 million for the years ended June 30, 2013, 2012 and 2011, respectively.

The estimated future amortization expense of purchased intangible assets as of June 30, 2013 is as follows (in thousands):

Year Ending June 30,	Amount

2014	$	8,380
2015		7,953
2016		7,953
2017		7,568
2018		42

	$	31,896

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details